Research
Energy balance
Liraglutide is approved for the treatment of obesity.
Liraglutide can be prescribed for obesity management.
StrongSupportsmedium confidence
Liraglutide was approved for the treatment of obesity.
Why this rating
The claim is based on regulatory approval.
Source
Investigational glucagon-like peptide-1 agonists for the treatment of obesity
Brian Tomlinson et al. · Expert Opinion on Investigational Drugs · 2016
reviewCited 24×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →